about
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies f...
Read More
16.73
-0.01
(-0.06%)
298.5K
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
GH Research PLC Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..